Update on omega-3 polyunsaturated fatty acids in early-stage psychotic disorders

Neuropsychopharmacology

Volumn 37, Issue 1, 2012, Pages 309-310

  Amminger, G Paul ^a,b   McGorry, Patrick D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; NICOTINE; OMEGA 3 FATTY ACID; PHOSPHOLIPID; PLACEBO;

DIET SUPPLEMENTATION; ERYTHROCYTE MEMBRANE; FIRST EPISODE SCHIZOPHRENIA; HUMAN; ICOSANOID METABOLISM; NEUROTRANSMISSION; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR BINDING; RISK FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; WHITE MATTER;

ADOLESCENT; ADULT; AGE FACTORS; DISEASE PROGRESSION; FATTY ACIDS, OMEGA-3; HUMANS; PSYCHOPHARMACOLOGY; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84856086688     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.187     Document Type: Note

References (7)

1. Amminger GP, Schä fer M, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM et al (2010). Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67: 146-154.
2. Assies J, Lieverse R, Vreken P, Wanders RJA, Dingemans PMJA, Linszen DH (2001). Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 49: 510-522. (Pubitemid 32226409)
3. Berger GE, Smesny S, Amminger GP (2006). Bioactive lipids in schizophrenia. Int Rev Psychiatry 18: 85-98. (Pubitemid 43791672)
4. Ellison-Wright I, Bullmore E (2009). Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res 108: 3-10.
5. McNamara R (2011). Omega-3 fatty acid deficiency: a preventable risk factor for schizophrenia? Schizophr Res 129: 215-216.
6. Peet M (2008). Omega-3 polyunsaturated fattyacids in the treatment of schizophrenia. Isr J Psychiatry Relat Sci Vol 45: 19-25.
7. Reddy RD, Keshavan MS, Yao JK (2004). Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull 30: 901-911 (Pubitemid 40469524)